LEISHMANIASIS VISCERAL TEST (InBios), ser, 1test, INS025
Valid Article
LEISHMANIASIS VISCERAL TEST (InBios)
CAUTION
This test is worded and codified by unit to make the order easier, but it is always packaged in kit of 25.
Definition
Rapid immunochromatographic test using the recombinant antigen rK39 for the detection of antibodies against visceral leishmaniasis (Kala-Azar).
This test is used as a first screening test for suspected Leishmaniasis cases.
Specifications
Components
- 25 Individually pouched test strips or 25 test strips in a vial with dessicant in the cap
- One vial of chase buffer solution
Technical specifications
- Specimen: serum
- Volume: 20 µl
- Time to result: 10 minutes
- Chase buffer: colourless liquid
- Performance varies depending of geographic zone (Kalazar Detect showed sensibility and specificity significantly different depending of geographic zone, as described in RDT multicentric evaluation WHO 2011 : https://www.who.int/publications/i/item/9789241502238)
Packaging & Labelling
Kit of 25 tests
Transport Dangerous Goods
Transport not regulated
Instructions for use
- Follow the instructions in the leaflet
- Can be performed on serum
- It is not recommended to use this test with capillary blood as it reduces significatively the performances
Precautions for Use
All biological samples must be considered as potentially infectious and handled with the usual precautions (compulsory wearing of gloves, hand washing, etc.).
Storage
- Store between 20 and 30ºC
- Do not freeze
- Shelf life: 24 months
- Not to be used beyond expiry date
Waste management
Incinerate the tests and the used materials.
Classification EC Regulation N° 1272/2008
Not classified as hazardous
MSF requirements
Screening test for detecting visceral leishmaniasis (Kala-Azar).
Donation received from WHO (manufacturer InBios) for the emergency stock Leishmaniasis of WHO.
Validated by Laurence Flevaud - OCBA Laboratory referent. July 2025